Treatment Patterns in Women Age 80 and Over With DCIS: A Report From the National Cancer Database

Published:April 21, 2022DOI:



      Despite an aging population, there are no established treatment guidelines for women with ductal carcinoma in situ (DCIS) age ≥80. Here we describe national treatment patterns and survival outcomes in older women with DCIS.

      Patients and Methods

      Women age ≥80 diagnosed with DCIS from 2005 to 2014 were identified using the National Cancer Database. χ2, Fisher's exact test, and logistic regression models were used to identify factors influencing receipt of breast surgery, and Kaplan-Meier method and Cox proportional hazard models were used to evaluate overall survival (OS).


      A total of 6,070 women with DCIS met inclusion criteria, of which the majority (98%) received surgery. Receipt of surgery was independently associated with age <90. OS was higher for those who received surgery compared to those who did not (HR 2.2 [1.72-2.83] P < .001).


      The vast majority of patients age ≥80 with DCIS in the National Cancer Database received primary surgical management, which was associated with a significant OS benefit. Considering comorbidities and patient fitness, surgical resection should be considered for all patients age ≥80 who are suitable operative candidates.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Breast Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Meijnen P
        • Oldenburg HSA
        • Peterse JL
        • Bartlelink H
        • Rutgers EJT.
        Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
        Ann Surg Oncol. 2007; 15: 235-243
        • Virnig BA
        • Tuttle TM
        • Shamliyan T
        • Kane RL.
        Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
        J Natl Cancer Inst. 2010; 102: 170-178
        • Hwang ES
        • Hyslop T
        • Lynch T
        • et al.
        The COMET (comparison of operative versus monitoring and endocrine therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
        BMJ Open. 2019; 9: e026797
        • Schonberg MA
        • Marcantonio ER
        • Li D
        • Silliman RA
        • Ngo L
        • McCarthy EP.
        Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.
        J Clin Oncol. 2010; 28: 2038-2045
        • DeSantis CE
        • Ma J
        • Goding Sauer A
        • Newman LA
        • Jemal A
        Breast cancer statistics, 2017, racial disparity in mortality by state.
        CA Cancer J Clin. 2017; 67: 439-448
      1. National Comprehensive Cancer Network. Breast cancer (version 2.2022). Available at: Accessed 12 Jan 2022.

        • Bouchardy C
        • Rapiti E
        • Fioretta G
        • et al.
        Undertreatment strongly decreases prognosis of breast cancer in elderly women.
        J Clin Oncol. 2003; 21: 3580-3587
        • Ryser MD
        • Weaver DL
        • Zhao F
        • et al.
        Cancer outcomes in DCIS patients without locoregional treatment.
        J Natl Cancer Inst. 2019; 111: 952-960
        • Akushevich I
        • Yashkin AP
        • Greenup RA
        • Hwang ES.
        A medicare-based comparative mortality analysis of active surveillance in older women with DCIS.
        NPJ Breast Cancer. 2020; 6: 30
        • Frebault J
        • Bergom C
        • Cortina CS
        • et al.
        Invasive breast cancer treatment patterns in women age 80 and over: a report from the national cancer database.
        Clin Breast Cancer. 2021; 22: S1526-S8209
      2. American College of Surgeons. 2020. About the national cancer database. Available at: Accessed 23 February 2020.

        • Cyr A
        • Gillanders WE
        • Aft RL
        • Eberlein TJ
        • Margenthaler JA.
        Breast cancer in elderly women (≥ 80 Years): variation in standard of care?.
        J Surg Oncol. 2011; 103: 201-206
        • Ferrigni E
        • Bergom C
        • Yin Z
        • Szabo A
        • Kong AL.
        Breast cancer in women aged 80 years or older: an analysis of treatment patterns and disease outcomes.
        Clin Breast Cancer. 2019; 19: 157-164
        • Mogal HD
        • Clark C
        • Dodson R
        • Fino NF
        • Howard-McNatt M.
        Outcomes after mastectomy and lumpectomy in elderly patients with early-stage breast cancer.
        Ann Surg Oncol. 2017; 24: 100-107
        • Kong AL
        • Nattinger AB
        • McGinley E
        • Pezzin LE.
        The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer.
        Breast Cancer Res Treat. 2018; 171: 477-488
      3. Society of Surgical Oncology. Choosing Wisely. 2016. Available at: Accessed December 18, 2018.

        • Esposito E
        • Sollazzo V
        • Di Micco R
        • et al.
        Can axillary node dissection be safely omitted in the elderly? a retrospective study on axillary management of early breast cancer in older women.
        Int J Surg. 2016; 33 (suppl): S114-S118
        • Limite G
        • Di Micco R
        • Sollazzo V
        • et al.
        Clinically cN0 breast cancer in elderly: what surgery?.
        Int J Surg. 2014; 12 (S130-S134)
        • Ryser MD
        • Worni M
        • Turner EL
        • Marks JR
        • Durrett R
        • Hwang ES.
        Outcomes of active surveillance for ductal carcinoma in situ: a computational risk analysis.
        J Natl Cancer Inst. 2016; 108: djv372
        • Grimm LJ
        • Hwang ES.
        Active surveillance for DCIS: the importance of selection criteria and monitoring.
        Ann Surg Oncol. 2016; 23: 4134-4136
        • Byng D
        • Retel VP
        • Schaapveld M
        • Wesseling J
        • van Harten WH.
        Treating (low-risk) DCIS patients” what can we learn from real-world cancer registry evidence?.
        Breast Cancer Res Treat. 2021; 187: 187-196
        • Ward EP
        • Weiss A
        • Blair SL.
        Incidence and treatments of DCIS in octogenarians: grade matters.
        Breast Cancer Res Treat. 2017; 165: 403-409
        • Ho A
        • Goenka A
        • Ishill N
        • et al.
        The effect of age in the outcome and treatment of older women with ductal carcinoma in situ.
        Breast. 2011; 20: 71-77
        • Jauhari Y
        • Gannon MR
        • Tsang C
        • et al.
        Surgery and adjuvant radiotherapy for unilateral ductal carcinoma in situ (DCIS) in women aged over 70 years: a population based cohort study.
        Eur J Surg Oncol. 2019; 45: 1378-1387
        • Anderson C
        • Winn AN
        • Dusetzina SB
        • Nichols HB.
        Endocrine therapy initiation among older women with ductal carcinoma in stiu.
        J Cancer Epidemiol. 2017; 2017: 6091709
        • Giannakeas V
        • Sopik V
        • Narod SA.
        Association of radiotherapy with survival in women treated for ductal carcinoma in situ with lumpectomy or mastectomy.
        JAMA Netw Open. 2018; 1: e181100
        • Smith BD
        • Haffty BG
        • Buchholz TA
        • et al.
        Effectiveness of radiation therapy in older women with ductal carcinoma in situ.
        J Natl Cancer Inst. 2006; 98: 1302-1310
        • Hughes KS
        • Schnaper LA
        • Berry D
        • et al.
        Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with elderly breast cancer.
        N Engl J Med. 2004; 351: 351
        • Rakovitch E
        • Nofech-Mozes S
        • Narod SA
        • et al.
        Can we select individuals with low risk ductal carcinoma in situ (DCIS)? a population-based outcomes analysis.
        Breast Cancer Res Treat. 2013; 138: 581-590
        • Biganzoli L
        • Wildiers H
        • Oakman C
        • et al.
        Management of eldelry patients with breast cancer: updated recommendations of the internal society of geriatric oncology (SIOG) and European society of breast cancer specialists (EUSOMA).
        Lancet Oncol. 2012; 13: 148-160
        • Wyld L
        • Reed M
        • Collins K
        • et al.
        Cluster randomized trial to evaluate the clinical benefits of decision support interventions for older women with operable breast cancer.
        in: 12th European Breast Cancer Conference. 138. European Breast Cancer Council, 2020 (Abstract 8B)
        • Clough-Gorr KM
        • Stuck AE
        • Thwin SS
        • Silliman RA.
        Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up.
        J Clin Oncol. 2010; 28: 380-386
        • Kimmick G
        • Li X
        • Fleming ST
        • et al.
        Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer.
        J Geriatr Oncol. 2017; 9: 214-220
        • Diab SG
        • Elledge RM
        • Clark GM.
        Tumor characteristics and clinical outcome of elderly women with breast cancer.
        J Natl Cancer Inst. 2000; 92: 550-556
        • Richardson LC
        • Henley SJ
        • Miller J
        • Massetti G
        Thomas CC. Patterns and trends in age-specific black-white differences in breast cancer incidence and mortality - United States, 1999-2014.
        MMWR Morb Mortal Wkly Rep. 2016; 65: 1093-1098
        • Mohile S
        • Dale W
        • Somerfield MR
        • et al.
        Practical assessment and management of vulnerabilities in older patients receiving chemotherapy.
        J Clin Oncol. 2018; 36: 2326-2347